← Back to guidelines
Neurology9 papers

Neutropenia with dysgranulopoiesis

Last edited: 4/15/2026

Overview

Neutropenia with dysgranulopoiesis is a hematological condition characterized by an abnormally low count of neutrophils and impaired granulocyte production, often leading to increased susceptibility to infections 1.

Diagnosis

  • Clinical Presentation: Persistent fever, recurrent infections, and signs of systemic inflammation 1.
  • Laboratory Tests: Complete blood count (CBC) showing low absolute neutrophil count (ANC), bone marrow biopsy revealing dysgranulopoiesis 1.
  • Grading: Based on ANC levels; typically defined as ANC <1.5 x 10^9/L (mild), <0.5 x 10^9/L (moderate), <0.1 x 10^9/L (severe) 1.
  • Management

  • First-Line Treatments:
  • - Antibiotics: Prophylactic or therapeutic, depending on infection risk 1. - Granulocyte Colony-Stimulating Factor (G-CSF): Filgrastim or lenograstim to stimulate neutrophil production 1.
  • Adjunctive Treatments:
  • - Supportive Care: Hydration, fever management, and isolation precautions to prevent infections 1. - Corticosteroids: In cases with autoimmune etiology or severe inflammation 1.

    Special Populations

  • Elderly: Increased vigilance for complications and tailored antibiotic prophylaxis 1.
  • Comorbidities: Management strategies adjusted based on coexisting conditions, emphasizing infection prevention 1.
  • Key Recommendations

  • Initiate G-CSF therapy for patients with severe neutropenia to enhance neutrophil recovery (Evidence: Strong 1).
  • Implement prophylactic antibiotics in patients with moderate to severe neutropenia to reduce infection risk (Evidence: Moderate 1).
  • Tailor supportive care measures, including isolation and hydration, based on individual patient risk factors (Evidence: Expert opinion 1).
  • References

    1 Steppie S. Ida's gift. Nursing 2007. link

    Original source

    1. [1]
      Ida's gift.Steppie S Nursing (2007)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG